76 related articles for article (PubMed ID: 3038304)
1. Proliferation-dependent topoisomerase II content as a determinant of antineoplastic drug action in human, mouse, and Chinese hamster ovary cells.
Sullivan DM; Latham MD; Ross WE
Cancer Res; 1987 Aug; 47(15):3973-9. PubMed ID: 3038304
[TBL] [Abstract][Full Text] [Related]
2. The Role of Intracellular Potassium in Cell Quiescence, Proliferation, and Death.
Marakhova II; Yurinskaya VE; Domnina AP
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255956
[TBL] [Abstract][Full Text] [Related]
3. A scalable, open-source implementation of a large-scale mechanistic model for single cell proliferation and death signaling.
Erdem C; Mutsuddy A; Bensman EM; Dodd WB; Saint-Antoine MM; Bouhaddou M; Blake RC; Gross SM; Heiser LM; Feltus FA; Birtwistle MR
Nat Commun; 2022 Jun; 13(1):3555. PubMed ID: 35729113
[TBL] [Abstract][Full Text] [Related]
4. TOP2B: The First Thirty Years.
Austin CA; Lee KC; Swan RL; Khazeem MM; Manville CM; Cridland P; Treumann A; Porter A; Morris NJ; Cowell IG
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30223465
[TBL] [Abstract][Full Text] [Related]
5. A mechanistic pan-cancer pathway model informed by multi-omics data interprets stochastic cell fate responses to drugs and mitogens.
Bouhaddou M; Barrette AM; Stern AD; Koch RJ; DiStefano MS; Riesel EA; Santos LC; Tan AL; Mertz AE; Birtwistle MR
PLoS Comput Biol; 2018 Mar; 14(3):e1005985. PubMed ID: 29579036
[TBL] [Abstract][Full Text] [Related]
6. Next generation high throughput DNA damage detection platform for genotoxic compound screening.
Sykora P; Witt KL; Revanna P; Smith-Roe SL; Dismukes J; Lloyd DG; Engelward BP; Sobol RW
Sci Rep; 2018 Feb; 8(1):2771. PubMed ID: 29426857
[TBL] [Abstract][Full Text] [Related]
7. DNA Topoisomerase II-alpha as a marker of cell proliferation in endocrine and other neoplasms.
Holden JA
Endocr Pathol; 1999 Jun; 10(2):97-102. PubMed ID: 27519213
[TBL] [Abstract][Full Text] [Related]
8. The ascidian natural product eusynstyelamide B is a novel topoisomerase II poison that induces DNA damage and growth arrest in prostate and breast cancer cells.
Liberio MS; Sadowski MC; Davis RA; Rockstroh A; Vasireddy R; Lehman ML; Nelson CC
Oncotarget; 2015 Dec; 6(41):43944-63. PubMed ID: 26733491
[TBL] [Abstract][Full Text] [Related]
9. Leukemia and benzene.
Snyder R
Int J Environ Res Public Health; 2012 Aug; 9(8):2875-93. PubMed ID: 23066403
[TBL] [Abstract][Full Text] [Related]
10. Topoisomerase II alpha and II beta expression in childhood acute lymphoblastic leukaemia: relation to prognostic factors and clinical outcome.
Lodge AJ; Hall AG; Reid MM; McIntosh GG; Steward M; Anderson JJ; Horne CH; Angus B
J Clin Pathol; 2001 Jan; 54(1):31-6. PubMed ID: 11271785
[TBL] [Abstract][Full Text] [Related]
11. Antitrypanosomal activity of fluoroquinolones.
Nenortas E; Burri C; Shapiro TA
Antimicrob Agents Chemother; 1999 Aug; 43(8):2066-8. PubMed ID: 10428939
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical study of DNA topoisomerase II in human gastric disorders.
Yabuki N; Sasano H; Kato K; Ohara S; Toyota T; Nagura H; Miyaike M; Nozaki N; Kikuchi A
Am J Pathol; 1996 Sep; 149(3):997-1007. PubMed ID: 8780403
[TBL] [Abstract][Full Text] [Related]
13. Etoposide-resistant human colon and lung adenocarcinoma cell lines exhibit sensitivity to homoharringtonine.
Wilkoff LJ; Dulmadge EA; Vasanthakumar G; Donahue JP
Cancer Chemother Pharmacol; 1993; 33(2):149-53. PubMed ID: 8261574
[TBL] [Abstract][Full Text] [Related]
14. Cellular models for multiple drug resistance in cancer.
Clynes M
In Vitro Cell Dev Biol; 1993 Mar; 29A(3 Pt 1):171-9. PubMed ID: 8096505
[No Abstract] [Full Text] [Related]
15. Topoisomerase expression in cancer cell lines and clinical samples.
Doyle LA
Cancer Chemother Pharmacol; 1994; 34 Suppl():S32-40. PubMed ID: 8070025
[TBL] [Abstract][Full Text] [Related]
16. Reduced levels of topoisomerase II alpha and II beta in a multidrug-resistant lung-cancer cell line.
Evans CD; Mirski SE; Danks MK; Cole SP
Cancer Chemother Pharmacol; 1994; 34(3):242-8. PubMed ID: 8004758
[TBL] [Abstract][Full Text] [Related]
17. Kinetic resistance to anticancer agents.
Dimanche-Boitrel MT; Garrido C; Chauffert B
Cytotechnology; 1993; 12(1-3):347-56. PubMed ID: 7764456
[TBL] [Abstract][Full Text] [Related]
18. Proliferation-associated nuclear antigen Ki-S1 is identical with topoisomerase II alpha. Delineation of a carboxy-terminal epitope with peptide antibodies.
Boege F; Andersen A; Jensen S; Zeidler R; Kreipe H
Am J Pathol; 1995 Jun; 146(6):1302-8. PubMed ID: 7539979
[TBL] [Abstract][Full Text] [Related]
19. Depletion of topoisomerase II in isolated nuclei during a glucose-regulated stress response.
Shen JW; Subjeck JR; Lock RB; Ross WE
Mol Cell Biol; 1989 Aug; 9(8):3284-91. PubMed ID: 2552289
[TBL] [Abstract][Full Text] [Related]
20. The topoisomerase II inhibitor VM-26 induces marked changes in histone H1 kinase activity, histones H1 and H3 phosphorylation, and chromosome condensation in G2 phase and mitotic BHK cells.
Roberge M; Th'ng J; Hamaguchi J; Bradbury EM
J Cell Biol; 1990 Nov; 111(5 Pt 1):1753-62. PubMed ID: 2172257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
